Colorectal cancer is the third most common type of cancer in both men and women and is the second leading cause of cancer death after lung cancer. Many colorectal cancers can be prevented through regular screening. Screening can find precancerous polyps—abnormal growths in the colon or rectum—so that they can be removed before they turn into cancer.
Several screening tests have been developed to help doctors find colorectal cancer early, when it may be more treatable. We know that detecting colorectal cancer at an early stage improves survival rates. The five year survival rate for people diagnosed with early stage colon cancer ranges from 53% to 92%, compared to only 11% for persons diagnosed with metastatic Stage IV colon cancer. While colon cancer occurs most often in people over the age of 50, there is an increasing incidence rate in younger individuals.
The guideline for colorectal cancer screening recommends that average-risk adults aged 45 years and older with no symptoms undergo regular screening. As a part of the screening process, all positive results on non-colonoscopy screening tests should be followed up with timely colonoscopy.
Jessica Taff, MD, a Hematologist/Oncologist with the RWJBarnabas Health medical group addresses some of the questions she is commonly asked about colorectal cancers. Watch here
Articles & Blogs
Investigators from the ECOG-ACRIN Cancer Research Group led by Howard S. Hochster, MD, FACP, associate director for clinical research and director of gastrointestinal oncology at Rutgers Cancer Institute of New Jersey, wanted to explore the anti-VEGFR antibody ramucirumab in second-line treatment. Read more
Along with maintaining a balanced diet and engaging in regular physical activity, screening for colorectal cancer is important. Colorectal cancer usually does not cause any symptoms until it is advanced and starts to spread through the body. If diagnosed at a later stage, the disease can be more challenging to treat and cure. If detected early, colorectal cancer can be treated more effectively. Read more
ScreenNJ was developed under the leadership of Rutgers Cancer Institute in partnership with the New Jersey Department of Health. The initiative is a collaboration of organizations across the state committed to reducing cancer incidence and mortality through outcomes-oriented, evidence-based cancer prevention and screening programs. The public can utilize this resource to find local colorectal (as well as lung) cancer screening programs and information about the types of testing and benefits. Learn more